MSTO2P and lung carcinoma: Similarly, the levels of EZH2 were increased in lung cancers as compared with normal tissues and its levels were correlated to the ones of the lncRNA MSTO2P, (a new positive regulator of EZH2 whose mechanism is unknown), data which were coherent since lncRNA MSTO2P can positively regulate EZH2 [130].